Treatment Benefit and the Risk of Suicidality in Multicenter, Randomized, Controlled Trials of Sertraline in Children and Adolescents
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to examine the balance between the benefits of treatment and the risk of suicidality in children and adolescents in multicenter, randomized, controlled trials of sertraline versus placebo. METHOD: The published literature was searched for multicenter, randomized, placebo-controlled trials of sertraline for pediatric mental disorders. Four trials were identified: Two (pooled) in pediatric major depressive disorder (MDD; Wagner 2003) and two in obsessive-compulsive disorder (OCD; March et al. 1998; POTS Team 2004). Using intent-to-treat (ITT) analysis populations, the authors calculated the number needed to treat (NNT) for response and remission and the number needed to harm (NNH) for suicidality, and their ratio, for each clinical trial. RESULTS: NNTs ranged from 2 to 10, indicating clinically meaningful benefits. Benefit was greater for OCD than for MDD, and for adolescents as compared with children in MDD. No age effect was apparent for OCD. Suicidality was reported in 8 patients (5 assigned to sertraline and 3 assigned to placebo). All but 1 (a placebo-treated patient in the Pfizer OCD trial) were enrolled in the sertraline MDD trial. The NNH for suicidality in MDD was 64. Treatment emergent suicidality was more common in children (NNH 28.7) than in adolescents (NNH 706.3). Because no patient developed suicidality in sertraline-treated OCD patients, the NNH for sertraline in OCD approaches infinity. CONCLUSIONS: With the stipulation that doctor and patient preferences necessarily play a critical role in the choice of treatment, NNT to NNH ratios indicate a positive benefit-to-risk ratio for sertraline in adolescents with MDD and in patients of all ages with OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
SCAHILL, L., RIDDLE, M. A., McSWIGGIN-HARDIN, M., ORT, S. I., KING, R. A., GOODMAN, W. K., CICCHETTI, D., & LECKMAN, J. F. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00023 · Cited by 2,045 · cited 2×
“The ARR is the percent response in the experimental group— the percent response in the control condition. often rephrased as the absolute benefit increase ABI).”
Obsessive Compulsive Disorder in Adolescence: An Epidemiological Study
FLAMENT, M. F., WHITAKER, A., RAPOPORT, J. L., DAVIES, M., BERG, C. Z., KALIKOW, K., SCEERY, W., & SHAFFER, D. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198811000-00018 · Cited by 684 · cited 1×
“Whereas obsessive-compulsive disorder (OCD) is less common—approximately in 200 young people are affected—it also 92 disrupts academic, social, and family functioning (Flament et al. 1988).”
Psychopathology Associated With Suicidal Ideation and Attempts Among Children and Adolescents
GOULD, M. S., KING, R., GREENWALD, S., FISHER, P., SCHWAB-STONE, M., KRAMER, R., FLISHER, A. J., GOODMAN, S., CANINO, G., & SHAFFER, D. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199809000-00011 · Cited by 600 · cited 1×
“Suicidality is uncommon in youth with OCD; conversely, depression is a significant contributor to nonfatal suicidal behavior and adolescents (Shaffer et al. 1996; Gould et al. 1998).”
The case for practical clinical trials in psychiatry.
March, J. S., Silva, S. G., Compton, S., Shapiro, M., Califf, R., & Krishnan, R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.836 · Cited by 240
Self-citation
Cited by
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
“Unauthorized reproduction of this article is prohibited. modest, although all positive contrasts did favor the combination (March et al., 2006b; Vitiello et al., 2006).”
BackgroundResultPsychological Treatments That Cause Harm
Lilienfeld, S. O. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00029.x · Cited by 959
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Children with obsessive-compulsive disorder: are they just “little adults”?
Kalra, S. K., & Swedo, S. E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37563 · Cited by 114
Metadata
- Authors
- March, J. S., Klee, B. J., & Kremer, C. M. E.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-03
- Volume
- 16
- Issue
- 1-2
- Pages
- 91-102
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2035339789
- Cited by
- 57
- References
- 7
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment Benefit and the Risk of Suicidality in Multicenter, Randomized, Controlled Trials of Sertraline in Children and Adolescents. https://app.cochat.ai/papers/10.1089/cap.2006.16.91
- The paper
- March, J. S., Klee, B. J., & Kremer, C. M. E. (2006). Treatment Benefit and the Risk of Suicidality in Multicenter, Randomized, Controlled Trials of Sertraline in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2006.16.91
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.